Pregnancy and Fertility Testing- Market Scope
Pregnancy testing is a diagnostic procedure aimed at determining a woman's pregnancy status by detecting the presence of human chorionic gonadotropin (hCG), a hormone produced during pregnancy. The pregnancy and fertility testing play vital roles in family planning and reproductive healthcare, offering crucial insights for individuals and couples seeking to comprehend and manage their reproductive health. Additionally, fertility testing proves instrumental in identifying potential issues and exploring suitable interventions to enhance the likelihood of conception.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
Key Companies Profiled | Abbott (United States), bioMerieux (France), Church and Dwight (New Jersey), DCC (Dubai), Geratherm Medical (Germany), Germaine Laboratories (United States), Kent Pharmaceuticals (India) and Swiss Precision Diagnostics (China) |
CAGR | 6.6% |
The global pregnancy & fertility testing products market is highly competitive. The major players in the market are evaluated based on their product and/or service offerings, financial statements, key developments, strategic approach to the market, position in the market, geographical penetration, and other key features Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Pregnancy and Fertility Testing- market throughout the predicted period.
Abbott (United States), bioMerieux (France), Church and Dwight (New Jersey), DCC (Dubai), Geratherm Medical (Germany), Germaine Laboratories (United States), Kent Pharmaceuticals (India) and Swiss Precision Diagnostics (China) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Prestige Brands (United States), P&G (United States), Quidel (United States) and Rite Aid (United States).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Pregnancy and Fertility Testing- market by Type , by Application (Hospitals, Clinics, Homecare, Diagnostics Centers and Others) and Region with country level break-up.
On the basis of geography, the market of Pregnancy and Fertility Testing- has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2023.
Market Leaders and their expansionary development strategies
In July 2023,2San a Supplier of self-Diagnostic test has partnered with proov to Distribute their proprietary at home fertility test in select Hy -Vee Stores across the eight in the Midwest.
In December 2021, Carrot Fertility, the leading global fertility healthcare and family-forming benefits provider for employers and health plans, announced new capabilities for members to perform at-home fertility hormone and related biomarker monitoring. This custom, one-of-a-kind test kit goes beyond traditional fertility hormone tests to offer a more complete picture of fertility health, enabling earlier action and interventions from the comfort of home.
Influencing Trend:
Development of more sensitive and accurate testing methods and Integration of digital and smartphone applications for fertility tracking
Market Growth Drivers:
Growing acceptance and accessibility of over-the-counter testing kits and Supportive government initiatives and policies regarding reproductive health
Challenges:
Navigating diverse regulatory landscapes across different regions and Compliance with evolving regulations and standards for fertility testing
Restraints:
Potential emotional impact and stress on individuals and couples undergoing testing and Lack of insurance coverage for fertility treatments and testing
Opportunities:
Integration with digital health platforms for comprehensive reproductive health management and Partnerships with tech companies for app-based fertility solutions
Key Target Audience
Manufacturing, Distributers, providers, suppliers and Others